Results 271 to 280 of about 126,022 (347)

Psychopathological Concomitants and Motivations Related to Misuse of Non‐Steroidal Anti‐Inflammatory Drugs and Paracetamol

open access: yesHuman Psychopharmacology: Clinical and Experimental, Volume 41, Issue 3, May 2026.
ABSTRACT Introduction Non‐steroidal anti‐inflammatory drugs (NSAIDs) and paracetamol are among the most commonly used medications worldwide. It has been suggested that the misuse of such medications is not uncommon. The objective of the present research was to explore prevalence, reported reasons and psychopathological concomitants related to NSAIDs ...
Francesco Saverio Bersani   +8 more
wiley   +1 more source

Integrating the Gestalt Model of Self With Psychedelic‐Assisted Psychotherapy

open access: yesThe Journal of Humanistic Counseling, Volume 65, Issue S1, Page S77-S88, May 2026.
ABSTRACT This theoretical integration paper employs a conceptual analysis methodology to synthesize the Gestalt model of self‐as‐process with Psychedelic Somatic Interactional Psychotherapy (PSIP). Unlike traditional psychedelic therapy models that defer therapeutic engagement to postsession integration, PSIP emphasizes an active, directive therapeutic
Travis R. Fox
wiley   +1 more source

Examining buprenorphine compared to methadone for likelihood of overdose during pregnancy, 2014–2021

open access: yesPregnancy, Volume 2, Issue 3, May 2026.
Abstract Objective To examine the likelihood of experiencing an overdose among women receiving any buprenorphine (with or without naloxone) compared to women receiving methadone during pregnancy. Methods Data from the MATernaL and Infant clinical NetworK (MAT‐LINK), a longitudinal surveillance system of pregnant woman–child dyads using electronic ...
Amy Board   +20 more
wiley   +1 more source

Talking to Your Patients About Alcohol, Marijuana, and Substance Use During Pregnancy. [PDF]

open access: yesPrim Care Companion CNS Disord
Hogan CS   +4 more
europepmc   +1 more source

Trends in toxicological findings and drug seizures of MDMA in New Zealand from 2010 to 2022

open access: yesJournal of Forensic Sciences, Volume 71, Issue 3, Page 1338-1350, May 2026.
Abstract 3,4‐Methylenedioxymethamphetamine (MDMA) or “ecstasy,” is a commonly used drug worldwide, including in New Zealand, where 4.8% of the population aged 15 years or over reported using it in a 2023/2024 survey. This study provides additional insights on MDMA prevalence data in New Zealand by reporting toxicology data from Coronial and driving ...
Thomas J. Sheehan   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy